CNL Healthcare Pptys (CHTH) Financials
Newest figures come from the 10-Q for Q3 FY2025, filed Nov 13, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CHTH SEC filings page.
CNL Healthcare Pptys Inc (CHTH) reported $385.5M in revenue over the twelve months to Sep 30, 2025, up 7.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.
The business is asset-heavy and debt-funded, with improving operating results but recurring accounting losses and cash flow shaped by depreciation.
Operating income reached$30.9M in FY2024, but net income was a loss of$14.5M . With interest expense at$45.9M and depreciation and amortization at$50.7M , financing costs and non-cash charges help explain why operating improvement has not produced bottom-line profit.
Revenue grew
Operating cash flow recovered
Financial Health Signals
We do not publish a peer-relative financial health score for CNL Healthcare Pptys Inc, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
CNL Healthcare Pptys Inc passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
CNL Healthcare Pptys Inc reported a net loss of $14.5M while generating $40.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
CNL Healthcare Pptys Inc earns $0.67 in operating income for every $1 of interest expense ($30.9M vs $45.9M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
CNL Healthcare Pptys Inc generated $99.3M in revenue in Q3 2025. This represents an increase of 7.0% from the same quarter a year earlier. Against the prior quarter it is up 2.0%.
CNL Healthcare Pptys Inc's EBITDA was $22.3M in Q3 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 7.6% from the same quarter a year earlier. Against the prior quarter it is down 1.8%.
CNL Healthcare Pptys Inc reported a net loss of $1.6M in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
CNL Healthcare Pptys Inc earned -$0.01 per diluted share (EPS) in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
CNL Healthcare Pptys Inc held $57.7M in cash against $565.0M in long-term debt as of Q3 2025.
CNL Healthcare Pptys Inc paid $0.03 per share in dividends in Q3 2025. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q3 2025.
Margins & Returns
CNL Healthcare Pptys Inc's operating margin was 9.5% in Q3 2025, reflecting core business profitability. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.3 percentage points.
CNL Healthcare Pptys Inc's net profit margin was -1.6% in Q3 2025, showing the share of revenue converted to profit. This is up 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.
CNL Healthcare Pptys Inc's quarterly ROE was -0.2% in Q3 2025: one quarter's net income over shareholder equity, not annualized. This is up 0.2 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q3 2025.
Capital Allocation
None of these metrics is reported for Q3 2025.
CHTH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Revenue | $99.3M+7.0% | $97.4M+7.1% | $95.6M+7.4% | $93.2M+7.8% | $92.8M+7.6% | $90.9M+6.7% | $89.1M+6.5% | $86.4M+6.0% |
| SG&A Expenses | $2.5M+37.8% | $2.2M-0.6% | $2.3M+5.4% | $2.5M-0.9% | $1.8M-8.6% | $2.2M-5.0% | $2.2M-1.2% | $2.5M+5.2% |
| Operating Income | $9.4M+15.8% | $9.6M-4.9% | $8.5M+33.7% | $6.4M+270.1% | $8.1M+63.6% | $10.0M+144.5% | $6.3M+122.5% | $1.7M+116.8% |
| EBITDA | $22.3M+7.6% | $22.7M+0.3% | $21.2M+12.3% | $19.3M+35.7% | $20.8M+19.0% | $22.7M+33.7% | $18.9M+16.0% | $14.2M-0.4% |
| Interest Expense | $10.9M-5.1% | $11.0M-3.5% | $11.0M-5.3% | $11.3M+0.9% | $11.5M+7.1% | $11.4M+11.5% | $11.6M+20.1% | $11.2M+57.6% |
| Income Tax | $181K+44.8% | $154K+25.2% | $162K+40.9% | $248K+3.8% | $125K+5.9% | $123K+33.7% | $115K+3.6% | $239K-25.1% |
| Net Income | -$1.6Mn/m | -$1.5Mn/m | -$2.6Mn/m | -$5.0Mn/m | -$3.2Mn/m | -$1.3Mn/m | -$5.0Mn/m | -$9.1Mn/m |
| EPS (Basic) | -$0.01n/m | -$0.01n/m | -$0.01 | -$0.03n/m | -$0.02n/m | -$0.01n/m | -$0.03n/m | -$0.05n/m |
| EPS (Diluted) | -$0.01n/m | -$0.01n/m | -$0.01 | -$0.03n/m | -$0.02n/m | -$0.01n/m | -$0.03n/m | -$0.05n/m |
| Diluted Shares (Avg) | 174M0.0% | 174M0.0% | 174M | N/A | 174M0.0% | 174M0.0% | 174M0.0% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
CHTH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.3B-2.5% | $1.3B-2.8% | $1.3B-2.4% | $1.3B-3.4% | $1.3B-3.5% | $1.3B-3.7% | $1.3B-4.0% | $1.4B-5.0% |
| Cash & Equivalents | $57.7M+14.2% | $53.2M+8.4% | $50.9M+20.3% | $44.0M-18.6% | $50.5M-5.6% | $49.1M-0.3% | $42.4M-3.7% | $54.1M-22.2% |
| Total Liabilities | $608.1M-1.1% | $603.1M-0.7% | $608.6M+0.2% | $607.6M-2.2% | $614.7M-1.4% | $607.3M-2.3% | $607.3M-2.3% | $621.5M-3.9% |
| Long-Term Debt | $565.0M-1.6% | $565.0M-1.6% | $570.0M-0.8% | $569.9M-2.6% | $574.2M-1.9% | $574.4M-1.9% | $574.6M-1.8% | $584.8M-4.1% |
| Total Equity | $693.6M-3.7% | $699.5M-4.5% | $704.9M-4.4% | $711.8M-4.3% | $720.1M-5.2% | $732.3M-4.9% | $737.6M-5.3% | $743.6M-5.8% |
| Retained Earnings | $54.6M-16.2% | $56.2M-17.8% | $57.7M-17.2% | $60.2M-19.4% | $65.2M-22.2% | $68.4M-23.4% | $69.7M-26.3% | $74.7M-25.6% |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.
CHTH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $13.4M+30.2% | $16.2M+19.7% | $14.3M+100.1% | $9.3M+27.1% | $10.3M+31.0% | $13.5M+18.3% | $7.1M+34.2% | $7.3M-22.4% |
| Depreciation & Amortization | $12.9M+2.2% | $13.2M+4.4% | $12.7M+1.5% | $12.9M+3.3% | $12.6M+1.2% | $12.6M-1.7% | $12.5M-6.6% | $12.5M-7.3% |
| Investing Cash Flow | -$4.4Mn/m | -$4.5Mn/m | -$2.3Mn/m | -$7.0M-172.7% | -$3.5M-410.3% | -$3.0Mn/m | -$2.7M-661.9% | $9.6Mn/m |
| Financing Cash Flow | -$4.5Mn/m | -$9.5Mn/m | -$4.3Mn/m | -$10.3Mn/m | -$4.8Mn/m | -$4.7Mn/m | -$14.7Mn/m | -$16.7Mn/m |
| Dividends Paid | $4.5M0.0% | $4.5M0.0% | $4.5M0.0% | $4.5M0.0% | $4.5M0.0% | $4.5M0.0% | $4.5M0.0% | $4.5M0.0% |
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Share Buybacks.
CHTH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 9.5%+0.7pp | 9.8%-1.2pp | 8.8%+1.7pp | 6.9%+4.9pp | 8.8%+3.0pp | 11.1%+6.2pp | 7.1%+3.7pp | 2.0%+1.0pp |
| Net Margin | -1.6%+1.8pp | -1.5%-0.1pp | -2.7%+3.0pp | -5.3%+5.2pp | -3.4%+2.9pp | -1.4%+4.8pp | -5.7%+1.3pp | -10.5%-3.1pp |
| Return on Equity | -0.2%+0.2pp | -0.2%0.0pp | -0.4%+0.3pp | -0.7%+0.5pp | -0.4%+0.3pp | -0.2%+0.5pp | -0.7%+0.1pp | -1.2%-0.5pp |
| Return on Assets | -0.1%+0.1pp | -0.1%0.0pp | -0.2%+0.2pp | -0.4%+0.3pp | -0.2%+0.1pp | -0.1%+0.3pp | -0.4%0.0pp | -0.7%-0.3pp |
| Debt-to-Equity | 0.810.0x | 0.810.0x | 0.810.0x | 0.800.0x | 0.800.0x | 0.780.0x | 0.780.0x | 0.790.0x |
| Liabilities-to-Equity | 0.880.0x | 0.860.0x | 0.860.0x | 0.850.0x | 0.850.0x | 0.830.0x | 0.820.0x | 0.840.0x |
| Asset Turnover | 0.080.0x | 0.070.0x | 0.070.0x | 0.070.0x | 0.070.0x | 0.070.0x | 0.070.0x | 0.060.0x |
Not reported in any period shown, so not listed: Gross Margin, Current Ratio, FCF Margin.
Where CNL Healthcare Pptys Inc Ranks
Frequently Asked Questions
CNL Healthcare Pptys Inc (CHTH) reported $366.0M in total revenue for fiscal year 2024. This represents a 7.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
CNL Healthcare Pptys Inc (CHTH) revenue grew by 7.2% year-over-year, from $341.5M to $366.0M in fiscal year 2024.
No, CNL Healthcare Pptys Inc (CHTH) reported a net loss of $10.6M over the trailing 12 months to September 30, 2025. In fiscal year 2024 it reported a net loss of $14.5M, with a net profit margin of -4.0%.
CNL Healthcare Pptys Inc (CHTH) had EBITDA of $81.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2024, CNL Healthcare Pptys Inc (CHTH) had $44.0M in cash and equivalents against $569.9M in long-term debt.
CNL Healthcare Pptys Inc (CHTH) had an operating margin of 8.5% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
CNL Healthcare Pptys Inc (CHTH) had a net profit margin of -4.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Yes, CNL Healthcare Pptys Inc (CHTH) paid $0.10 per share in dividends during fiscal year 2024.
CNL Healthcare Pptys Inc (CHTH) has a return on equity of -2.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
CNL Healthcare Pptys Inc (CHTH) generated $40.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
CNL Healthcare Pptys Inc (CHTH) had $1.3B in total assets as of fiscal year 2024, including both current and long-term assets.
CNL Healthcare Pptys Inc (CHTH) had a debt-to-equity ratio of 0.80 as of fiscal year 2024. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
CNL Healthcare Pptys Inc (CHTH) had a liabilities-to-equity ratio of 0.85 as of fiscal year 2024, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
CNL Healthcare Pptys Inc (CHTH) had a return on assets of -1.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
CNL Healthcare Pptys Inc (CHTH) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
CNL Healthcare Pptys Inc (CHTH) reported a net loss of $14.5M while generating $40.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
CNL Healthcare Pptys Inc (CHTH) has an interest coverage ratio of 0.67x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.